Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 23

1.

Inflammatory Signals shift from adipose to liver during high fat feeding and influence the development of steatohepatitis in mice.

Stanton MC, Chen SC, Jackson JV, Rojas-Triana A, Kinsley D, Cui L, Fine JS, Greenfeder S, Bober LA, Jenh CH.

J Inflamm (Lond). 2011 Mar 16;8:8. doi: 10.1186/1476-9255-8-8.

2.

P518/Qrfp sequence polymorphisms in SAMP6 osteopenic mouse.

Zhang Q, Qiu P, Arreaza MG, Simon JS, Golovko A, Laverty M, Vassileva G, Gustafson EL, Rojas-Triana A, Bober LA, Hedrick JA, Monsma FJ Jr, Greene JR, Bayne ML, Murgolo NJ.

Genomics. 2007 Nov;90(5):629-35. Epub 2007 Sep 17.

3.

Characterization of peripheral human cannabinoid receptor (hCB2) expression and pharmacology using a novel radioligand, [35S]Sch225336.

Gonsiorek W, Hesk D, Chen SC, Kinsley D, Fine JS, Jackson JV, Bober LA, Deno G, Bian H, Fossetta J, Lunn CA, Kozlowski JA, Lavey B, Piwinski J, Narula SK, Lundell DJ, Hipkin RW.

J Biol Chem. 2006 Sep 22;281(38):28143-51. Epub 2006 Jun 5.

4.

A novel cannabinoid peripheral cannabinoid receptor-selective inverse agonist blocks leukocyte recruitment in vivo.

Lunn CA, Fine JS, Rojas-Triana A, Jackson JV, Fan X, Kung TT, Gonsiorek W, Schwarz MA, Lavey B, Kozlowski JA, Narula SK, Lundell DJ, Hipkin RW, Bober LA.

J Pharmacol Exp Ther. 2006 Feb;316(2):780-8. Epub 2005 Oct 28.

PMID:
16258021
5.

The toxicity of SCH 351591, a novel phosphodiesterase-4 inhibitor, in Cynomolgus monkeys.

Losco PE, Evans EW, Barat SA, Blackshear PE, Reyderman L, Fine JS, Bober LA, Anthes JC, Mirro EJ, Cuss FM.

Toxicol Pathol. 2004 May-Jun;32(3):295-308.

PMID:
15204971
6.

Impairment of leukocyte trafficking in a murine pleuritis model by IL-4 and IL-10.

Fine JS, Rojas-Triana A, Jackson JV, Engstrom LW, Deno GS, Lundell DJ, Bober LA.

Inflammation. 2003 Aug;27(4):161-74.

PMID:
14527170
7.

Regulatory effects of interleukin-4 and interleukin-10 on human neutrophil function ex vivo and on neutrophil influx in a rat model of arthritis.

Bober LA, Rojas-Triana A, Jackson JV, Leach MW, Manfra D, Narula SK, Grace MJ.

Arthritis Rheum. 2000 Dec;43(12):2660-7.

8.

Evaluation of chemokine- and phlogistin-mediated leukocyte chemotaxis using an in vivo sponge model.

Fine JS, Jackson JV, Rojas-Triana A, Bober LA.

Inflammation. 2000 Aug;24(4):331-46.

PMID:
10850855
9.

A specific stimulator of granulocyte colony-stimulating factor accelerates recovery from cyclophosphamide-induced neutropenia in the mouse.

Fine JS, Cai XY, Justice L, Gommoll CP Jr, Hamilton LD, Waters TA, Narula SK, Bober LA, Grace MJ.

Blood. 1997 Jul 15;90(2):795-802.

PMID:
9226180
10.

The effects of colony stimulating factors on human monocyte cell function.

Bober LA, Grace MJ, Pugliese-Sivo C, Rojas-Triana A, Sullivan LM, Narula SK.

Int J Immunopharmacol. 1995 May;17(5):385-92.

PMID:
7591362
11.

The effect of GM-CSF and G-CSF on human neutrophil function.

Bober LA, Grace MJ, Pugliese-Sivo C, Rojas-Triana A, Waters T, Sullivan LM, Narula SK.

Immunopharmacology. 1995 Mar;29(2):111-9.

PMID:
7539779
12.

IL-4 induces neutrophilic maturation of HL-60 cells and activation of human peripheral blood neutrophils.

Bober LA, Waters TA, Pugliese-Sivo CC, Sullivan LM, Narula SK, Grace MJ.

Clin Exp Immunol. 1995 Jan;99(1):129-36.

13.

Human IL-10 reduces the number of IL-4-induced IgE B cells in cultures of atopic mononuclear cells.

Bober LA, Grace MJ, Pugliese-Sivo C, Waters TA, Sullivan LM, Narula SK.

Int Arch Allergy Immunol. 1994 Sep;105(1):26-31.

PMID:
8086826
14.

Potential interaction of interleukin-4 with endogenous cytokines in vivo.

Sullivan LM, Bober LA, Grace MJ, Braun S, Macosko HD, Payvandi F, Pugliese-Sivo CC, Narula SK.

Pathobiology. 1994;62(2):59-72.

PMID:
7945914
15.

Inhibition of collagen II-induced arthritis in mice--a comparison of the effects of Sch 24937, immunosuppressants and nonsteroidal antiinflammatory drugs on the clinical expression of disease.

Smith SR, Pennline KJ, Bober LA, Kenworthy-Bott L, Phillips L, Pellerito F, da Fonseca M, Terminelli C.

Int J Immunopharmacol. 1990;12(2):165-73.

PMID:
2329010
16.

A cross-reactive idiotype on anti-collagen antibodies in collagen-induced arthritis: identification and relevance to disease.

Nagler-Anderson C, van Vollenhoven RF, Gurish MF, Bober LA, Siskind GW, Thorbecke GJ.

Cell Immunol. 1988 May;113(2):447-61.

PMID:
2452021
17.

Suppression of type II collagen-induced arthritis by intragastric administration of soluble type II collagen.

Nagler-Anderson C, Bober LA, Robinson ME, Siskind GW, Thorbecke GJ.

Proc Natl Acad Sci U S A. 1986 Oct;83(19):7443-6.

18.

Antiinflammatory activity of substituted 6-hydroxypyrimido[2,1-f]purine-2,4,8(1H,3H,9H)-triones. Atypical nonsteroidal antiinflammatory agents.

Blythin DJ, Kaminski JJ, Domalski MS, Spitler J, Solomon DM, Conn DJ, Wong SC, Verbiar LL, Bober LA, Chiu PJ, et al.

J Med Chem. 1986 Jun;29(6):1099-113.

PMID:
3086558
19.

Inhibition of collagen II arthritis by simultaneous administration of concanavalin A and other substances with antigen emulsion.

Bober LA, Tivey LC, DaFonseca M, Smith SR, Watnick AS.

Immunopharmacology. 1985 Apr;9(2):97-107.

PMID:
3997507
20.

Endotoxin enhancement of plasma cell tumor development in mice given injections of mineral oil.

Bober LA, Kranepool MJ, Bojko C, Steiner G, Hollander VP.

Cancer Res. 1976 Jun;36(6):1947-9.

21.

Inhibitory effect of endotoxin on the growth of plasma cell tumor.

Bober LA, Kranepool MJ, Hollander VP.

Cancer Res. 1976 Mar;36(3):927-9.

22.
23.

Stimulation of the hemagglutinin response of aged mice by cell-free lymphoid tissue fractions and bacterial endotoxin.

Strausser HR, Bober LA, Bucsi RA, Shillcock JA, Goldstein AL.

Exp Gerontol. 1971 Oct;6(5):373-8. No abstract available.

PMID:
5126574

Supplemental Content

Loading ...
Support Center